What question did this study set out to answer?

April 17, 2026Open Access

The registration status of maternal, newborn, and child health medical products: evidence from 9 countries

Key Points

Evaluate the registration status of maternal, newborn, and child health medical products across nine countries.
Analyzed registration processes in selected countries.
Identified flaws in national systems for medical product registration.
Assessed the availability of essential MNCH products.
Many life-saving MNCH products are unavailable due to flawed registration processes.
Recommendations include prioritizing the registration of public health medicines.
Streamlining procedures is essential to improve health for women and children.

Abstract

Some life-saving MNCH products are not available because national registration processes are flawed. Consequently, governments and donors must invest in changes to streamline procedures to register vital medicines to protect the health of women and children. To maximise health outcomes, countries should prioritise the registration of products of public health importance, including MNCH medicines.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Jane Briggs

Kate Kikule

Helena Walkowiak

Journals

Journal of Pharmaceutical Policy and Practice

Actions

Institutions

St George's, University of London

Inter-American Development Bank

Muhimbili University of Health and Allied Sciences

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

The registration status of maternal, newborn, and child health medical products: evidence from 9 countries

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study